Grown Rogue International (GRUSF) Cash from Investing Activities (2013 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Cash from Investing Activities of -$2.9 million in Q1 2026, down 100.0% quarter-over-quarter from $1955.8 billion in Q4 2025, and down 761.12% on a YoY basis from $434808.6 in Q1 2025.
Grown Rogue International (GRUSF) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Grown Rogue International's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 761.12% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at $1955.8 billion (up 28569547.93% YoY), while the FY2025 annual figure was -$6.9 million, up 23.4% from the prior year.
- Cash from Investing Activities was -$2.9 million for Q1 2026 at Grown Rogue International, down from $1955.8 billion in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1955.8 billion in Q4 2025 to a low of -$2.9 million in Q1 2026.
- Historically, Cash from Investing Activities has averaged $217.3 billion across 4 years, with a median of -$1.9 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 103863188.84% in 2025, then tumbled 761.12% in 2026.
- A 4-year view of Cash from Investing Activities shows it stood at -$2.1 million in 2023, then grew by 10.44% to -$1.9 million in 2024, then surged by 103863188.84% to $1955.8 billion in 2025, then tumbled by 100.0% to -$2.9 million in 2026.
- The last three Cash from Investing Activities figures came in at -$2.9 million (Q1 2026), $1955.8 billion (Q4 2025), and -$394324.2 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -2.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.87 Mn |
| Mar 31, 2026 | -2.87 Mn |
| Dec 31, 2025 | 1,955.77 Bn |
| Dec 31, 2025 | 1,955.77 Bn |
| Jun 30, 2025 | -394,324.22 |
| Jun 30, 2025 | -394,324.22 |
| Mar 31, 2025 | -333,822.00 |
| Mar 31, 2025 | -333,822.00 |
| Dec 31, 2024 | -1.88 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | -2.19 Mn |
| Oct 31, 2023 | -2.10 Mn |
| Oct 31, 2023 | -2.10 Mn |
| Jul 31, 2023 | -910,381.00 |
| Jul 31, 2023 | -910,381.00 |
| Oct 31, 2021 | -409.08 Bn |
| Oct 31, 2021 | -409.08 Bn |